Dialysis News and Research

Latest Dialysis News and Research

Tolvaptan improves kidney health in polycystic kidney disease

A vasopressin V2-receptor blocker slows the increase in total kidney volume and decline in kidney function in patients with autosomal dominant polycystic kidney disease, report US researchers.

12 Nov 2012

New communication training could help nephrology fellows to discuss serious news with patients

Kidney specialists, or nephrologists, care for a medically complex population and frequently must discuss serious news with patients: giving a diagnosis of kidney disease, explaining the risks and benefits of treatments, and defining care goals at the end of life. Yet nephrologists do not routinely receive formal education on how to engage in these types of conversations.

9 Nov 2012

Tengion receives U.S. patent allowance titled ‘Isolated Renal Cells and Uses Thereof’

Tengion, Inc., a leader in regenerative medicine, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application No. 12/617,721, titled "Isolated Renal Cells and Uses Thereof."

5 Nov 2012

Study highlights potential treatment that reduces kidney growth

Autosomal-dominant polycystic kidney disease (ADPKD) is one of the most common genetic disorders, affecting one in every 1,000 people and responsible for up to ten percent of patients on dialysis worldwide. The disease is characterized by the development of cysts that lead to progressive kidney failure and necessitate dialysis or a kidney transplant in most patients aged around fifty. Moreover, the persistent cyst growth causes high blood pressure and painful complications.

5 Nov 2012

New information related to kidney transplantation

Three studies presented during the American Society of Nephrology's Annual Kidney Week provide new information related to kidney transplantation—specifically, the post-transplant health of kidney donors and the racial disparities faced by children in need of transplants.

3 Nov 2012

State of glycocalyx barrier indicates vascular risk in dialysis patients

The glycocalyx barrier – a mesh of proteoglycans and associated glycosaminoglycans present on vascular endothelium – is impaired in patients with renal failure, probably contributing to their predisposition to endothelial dysfunction and vascular disease, say researchers.

2 Nov 2012

Takeda, Affymax announce data from OMONTYS Phase 3 studies on anemia due to CKD

Affymax, Inc. and Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) today announced the presentation of post-hoc sub-group analyses of the EMERALD Phase 3 studies that evaluated OMONTYS (peginesatide) Injection, an erythropoiesis-stimulating agent (ESA), for the treatment of anemia due to chronic kidney disease (CKD) in adult dialysis patients.

2 Nov 2012

FibroGen announces presentation of FG-4592 Phase 2 data on anemia at ASN Kidney Week 2012

FibroGen, Inc., today announced that two abstracts relating to FG-4592, its oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) clinical candidate for the treatment of anemia in chronic kidney disease, have been accepted for oral and poster presentations at the American Society of Nephrology (ASN) Kidney Week 2012.

1 Nov 2012

State roundup: Hurricane Sandy has east coast hospitals scrambling

Healthcare providers on the East Coast have spent the weekend preparing for Hurricane Sandy, with hospitals canceling elective surgeries and discharging patients to free up beds.

30 Oct 2012

CTCtrap can capture circulating tumour cells in cancer patients

The 7.5 millilitres of blood contained in a standard sample tube is not nearly enough to detect circulating tumour cells (CTCs) in the blood of patients with metastatic breast cancer, prostate cancer, or colorectal cancer with a high enough degree of reliability. These CTCs are the cause of metastases in cancer patients. If they can be effectively characterized, it is possible to arrive at a prognosis and to determine the most effective course of treatment.

26 Oct 2012

American Society of Nephrology establishes new foundation

The American Society of Nephrology (ASN) has announced the creation of a new foundation—the ASN Foundation for Kidney Research—to propel major research advances in the treatment of kidney patients, and reach a cure for a disease that affects millions across the globe.

From Baxter International Inc. 26 Oct 2012

Thrasos completes $35 Million financing for development of THR-184 against AKI

Thrasos Therapeutics announced that it has completed a $35 Million (U.S.) financing for the development of THR-184, its lead product candidate for the treatment of acute kidney injury (AKI).

25 Oct 2012

Simple-to-use risk score can identify low-risk STEMI patients for early discharge

A simple-to-use risk score can identify low-risk patients following a severe heart attack (STEMI) and may provide an opportunity to employ early discharge strategies to reduce length of hospital stay and save hospital costs without compromising the safety of the patient, based on a study presented by the Minneapolis Heart Institute Foundation on Oct. 23 at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) conference.

24 Oct 2012

ZOLL Medical announces new Tokyo-based subsidiary

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions and a wholly owned U.S. subsidiary of Asahi Kasei, has established Asahi Kasei ZOLL Medical Corporation (AZM) as its Japanese subsidiary effective November 5.

24 Oct 2012

Damage of endothelial glycocalyx may lead to heart troubles in kidney failure patients

Individuals with kidney failure often develop heart problems, but it's not clear why. A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) provides evidence that their kidneys' inability to excrete waste products in the urine, which leads to build-up of these products in the blood, may damage the sugary lining of blood vessels and lead to heart troubles.

20 Oct 2012

Study hopes to improve the outlook for native Americans with kidney disease

Americans have a 1 in 10 chance of suffering from kidney disease, according to statistics from the Centers for Disease Control and Prevention. For Native Americans, the risk doubles.

19 Oct 2012

Chloride-restrictive intravenous strategy may decrease incidence of AKI among critically ill patients

In a pilot study assessing the effect of different levels of chloride in intravenous fluids administered to critically ill patients in an intensive care unit, restricting the amount of chloride administration was associated with a significant decrease in the incidence of acute kidney injury and the use of renal replacement therapy, according to a study in the October 17 issue of JAMA.

17 Oct 2012

Dialysis News and Research

Latest Dialysis News and Research

Tolvaptan improves kidney health in polycystic kidney disease

New communication training could help nephrology fellows to discuss serious news with patients

Tengion receives U.S. patent allowance titled ‘Isolated Renal Cells and Uses Thereof’

Study highlights potential treatment that reduces kidney growth

New information related to kidney transplantation

State of glycocalyx barrier indicates vascular risk in dialysis patients

Takeda, Affymax announce data from OMONTYS Phase 3 studies on anemia due to CKD

FibroGen announces presentation of FG-4592 Phase 2 data on anemia at ASN Kidney Week 2012

State roundup: Hurricane Sandy has east coast hospitals scrambling

CTCtrap can capture circulating tumour cells in cancer patients

American Society of Nephrology establishes new foundation

Thrasos completes $35 Million financing for development of THR-184 against AKI

Simple-to-use risk score can identify low-risk STEMI patients for early discharge

ZOLL Medical announces new Tokyo-based subsidiary

Damage of endothelial glycocalyx may lead to heart troubles in kidney failure patients

Study hopes to improve the outlook for native Americans with kidney disease

Chloride-restrictive intravenous strategy may decrease incidence of AKI among critically ill patients

Study evaluates international data on kidney transplantation

Simple quiz could help doctors determine kidney dialysis patients at risk of death

Modifying factors may be responsible for non-diabetic kidney disease in African-Americans

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Dialysis News and Research

Latest Dialysis News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in